CHRISTUS Transplant Institute

Recent papers from CHRISTUS Transplant Institute

1. Improved Outcomes with TKI Maintenance Following Brexucabtagene Autoleucel in Philadelphia-chromosome ALLBlood Advances · 2026
2. Screening, diagnosing, and managing perinatal depression: Review of SIX national guidelinesEuropean Journal of Obstetrics & Gynecology and Reproductive Biology · 2026
3. Need for kidney transplantation following vascularized composite allotransplantation: an international, multi-center case seriesOrthoplastic Surgery · 2026
4. SPAP: Soluble Human Plasma Proteoform Analysis via Acetonitrile Precipitation and Top-Down Mass SpectrometryJournal of the American Society for Mass Spectrometry · 2025
5. The impact of social determinants of health on outcomes of brexucabtagene autoleucel in adults with relapsed/refractory B-cell acute lymphoblastic leukemiaBone Marrow Transplantation · 2025
6. 2025 SCAI Clinical Practice Guidelines for the Management of Chronic Venous DiseaseJournal of the Society for Cardiovascular Angiography & Interventions · 2025
7. Outcomes of brexucabtagene autoleucel in patients with relapsed/refractory acute lymphoblastic leukemia with CNS involvementBlood Advances · 2025
8. Determinants of Outcomes for Acute Myeloid Leukemia Patients Treated in a Community-Based Specialized Versus Non-Specialized Hospital SettingClinical Hematology International · 2024
9. Majority Rules? Assessing Access to Kidney Transplantation in a Predominantly Hispanic PopulationKidney360 · 2024
10. Impact of Prior Inotuzumab Ozogamicin Treatment on Brexucabtagene Autoleucel outcomes in Adults with B-cell ALLBlood Advances · 2024
11. Use of HBsAg-positive donors in liver transplantation: An ILTS-EASL-AASLD multisociety surveyLiver Transplantation · 2024
12. Impact of Intravenous Immunoglobulin Replacement Therapy on Hypogammaglobulinemia and Infection in Lung Transplant RecipientsOBM Transplantation · 2024
13. Impact of Cumulative 6 mg/kg Antithymocyte Globulin on Early Posttransplant Outcomes in Kidney Transplant Recipients with Delayed Graft FunctionProgress in Transplantation · 2024
14. Genotype, oxidase status, and preceding infection or autoinflammation do not affect allogeneic HCT outcomes for CGDBlood · 2023
15. Utilization of donor‐derived Cell‐Free DNA in pediatric kidney transplant recipients: A single center studyPediatric Transplantation · 2023
16. Prospective PTCTC trial of myeloablative haplo-BMT with posttransplant cyclophosphamide for pediatric acute leukemiasBlood Advances · 2023
17. Poor Outcomes of Patients With NAFLD and Moderate Renal Dysfunction or Short-Term Dialysis Receiving a Liver Transplant AloneTransplant International · 2022
18. The diagnosis of severe combined immunodeficiency: Implementation of the PIDTC 2022 DefinitionsJournal of Allergy and Clinical Immunology · 2022
19. Early antimicrobial prophylaxis in autologous stem cell transplant recipients: Conventional versus an absolute neutrophil count‐driven approachTransplant Infectious Disease · 2021
20. Return to Work Among Young Adult Survivors of Allogeneic Hematopoietic Cell Transplantation in the United StatesBiology of Blood and Marrow Transplantation · 2021